Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

IMDX holding history

Insight Molecular Diagnostics Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMDX overviewAll 13F holders of IMDXFull Q2 2026 holdings

Shares (Q2 2026)
53,276
Value
$314.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IMDX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202653,276$314.3K<0.1%+30,525+134.2%AddedHolders
Q1 202622,751$74.6K<0.1%+19,810+673.6%AddedHolders
Q4 20252,941$22.1K<0.1%+227+8.4%AddedHolders
Q3 20252,714$9.01K<0.1%−12,651−82.3%ReducedHolders
Q2 202515,365$46.4K<0.1%+12,711+478.9%AddedHolders
Q1 20252,654$8.12K<0.1%−60−2.2%ReducedHolders
Q4 20242,714$6.46K<0.1%+1,879+225.0%AddedHolders
Q3 2024835$2.38K<0.1%00.0%UnchangedHolders
Q2 2024835$2.46K<0.1%−29−3.4%ReducedHolders
Q1 2024864$2.53K<0.1%−515−37.3%ReducedHolders
Q4 20231,379$3.45K<0.1%+354+34.5%AddedHolders
Q3 20231,025$3.20K<0.1%−1,161−53.1%ReducedConverted for a 1-for-20 splitHolders
Q2 202343,723$10.1K<0.1%+24,886+132.1%AddedHolders
Q1 202318,837$6.67K<0.1%−17,977−48.8%ReducedHolders
Q4 202236,814$11.8K<0.1%+11,239+43.9%AddedHolders
Q3 202225,575$19.0K<0.1%+5,569+27.8%AddedHolders
Q2 202220,006$18.0K<0.1%+1,150+6.1%AddedHolders
Q1 202218,856$28.0K<0.1%−15,412−45.0%ReducedHolders
Q4 202134,268$74.0K<0.1%+4,547+15.3%AddedHolders
Q3 202129,721$105.0K<0.1%−17,056−36.5%ReducedHolders
Q2 202146,777$268.0K<0.1%−7,573−13.9%ReducedHolders
Q1 202154,350$282.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.